Lilak v. Glaxo SmithKline Corporate Inc.
| Safdar Lilak |
| Glaxo SmithKline Corporate Inc. |
| 1:2011cv03395 |
| December 29, 2011 |
| US District Court for the District of Colorado |
| Denver Office |
| Arapahoe |
| Philip A. Brimmer |
| Michael J. Watanabe |
| Personal Injury- Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
49
FINAL JUDGMENT by Clerk re: 48 Order. By Judge Philip A. Brimmer on 9/28/12. (mnfsl, )
|
|
Filing
48
ORDER. The 40 Recommendation of United States Magistrate Judge is accepted. Defendant GlaxoSmithKline, LLC's 15 Motion to Dismiss is granted. This case is dismissed in its entirety. By Judge Philip A. Brimmer on 9/26/12.(mnfsl, )
|
|
Filing
47
MINUTE ORDER denying 44 After Scheduling Conference, of March 6th, 2012 & 07/23/12 Rule D.C.Colo.LCivR16.1/16.2 Flurry of Motions & Objections to MJW Recommendation Plaintiff Proposes Following. By Magistrate Judge Michael J. Watanabe on 8/21/12.(mnfsl, )
|
|
Filing
38
MINUTE ORDER granting 35 Motion to Strike. Plaintiff's First Amended Complaint 34 and "Correction" Plaintiff's First Amended Complaint 37 are STRICKEN. By Magistrate Judge Michael J. Watanabe on 7/12/12.(pabcd)
|
|
Filing
33
ORDER granting 31 Motion to Strike Plaintiff's Response Opposing Defense's Reply Amended Response of Plantiff to Pending Motion of Defense Plaintiff's Intent Notice for Summary Judgement [sic] Prusuant to FRCP Rule 56, 12(C) & Rule 50. Plaintiff's 27 RESPONSE Opposing Defense's Reply Amended Response of Plantiff to Pending Motion of Defense Plaintiff's Intent Notice for Summary Judgement Pursuant to FRCP Rule 56, 12(C) & Rule 50 is stricken in its entirety. By Magistrate Judge Michael J. Watanabe on 4/6/12.(mnfsl, )
|
|
Filing
5
ORDER Status Conference for Pro Se Plaintiff set for 3/6/2012 11:00 AM in Courtroom A 502 before Magistrate Judge Michael J. Watanabe, by Magistrate Judge Michael J. Watanabe on 1/23/2012. (mjwcd)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Colorado District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Lilak v. Glaxo SmithKline Corporate Inc. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Safdar Lilak | |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Glaxo SmithKline Corporate Inc. | |
| Represented By: | Adam Patrick O'Brien |
| Represented By: | Mary Alice Wells |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
